These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 772805

  • 1. Chemical and biological properties of hydrosoluble fraction of BCG.
    Sato H, Yokosawa A, Arai H, Motomiya M, Kurita K.
    Sci Rep Res Inst Tohoku Univ Med; 1975 Dec; 22(3-4):33-7. PubMed ID: 772805
    [No Abstract] [Full Text] [Related]

  • 2. [Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin].
    Kulagin PP, Martynova VA.
    Probl Tuberk; 1967 Dec; 45(9):74-7. PubMed ID: 4975371
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on the step-wise extraction of BCG cell surface components and immunological properties of the extracts].
    Shimono T.
    Nihon Saikingaku Zasshi; 1977 Mar; 32(2):369-91. PubMed ID: 327115
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I, Kanetsuna F, Taniyama T, Yamamura Y, Hori M.
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
    Janaszek W.
    Med Dosw Mikrobiol; 1983 Mar; 35(2):97-105. PubMed ID: 6369043
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Experimental study of BCG-M vaccine with a lowered antigen dose].
    Iablokova TB, Pisarenko NN, Levi DT, Kazachkova TE, Nesterenko LA.
    Probl Tuberk; 1985 Mar; (6):52-5. PubMed ID: 3900992
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
    Nyabenda J, Pierre M, Keuterickx F, de Backer P.
    Dev Biol Stand; 1986 Mar; 58 ( Pt A)():43-52. PubMed ID: 3297875
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy of guinea pig cancer with BCG.
    Zbar B.
    Johns Hopkins Med J Suppl; 1974 Mar; 3():121-30. PubMed ID: 4608693
    [No Abstract] [Full Text] [Related]

  • 14. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DN.
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [Abstract] [Full Text] [Related]

  • 15. Some immunological and toxic properties of mycobacteria grown in vivo.
    Kondo E, Kanai K.
    Jpn J Med Sci Biol; 1974 Feb; 27(1):53-7. PubMed ID: 4600526
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of the immune response by BCG: a review.
    Murahata RI, Mitchell MS.
    Yale J Biol Med; 1976 Jul; 49(3):283-91. PubMed ID: 785826
    [No Abstract] [Full Text] [Related]

  • 18. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.